Compare HALO & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | ESAB |
|---|---|---|
| Founded | 1998 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 8.1B |
| IPO Year | 2001 | 2022 |
| Metric | HALO | ESAB |
|---|---|---|
| Price | $68.83 | $106.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $78.18 | ★ $138.56 |
| AVG Volume (30 Days) | ★ 1.2M | 707.6K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.56 | ★ 3.67 |
| Revenue | $151,862,000.00 | ★ $2,842,555,000.00 |
| Revenue This Year | $28.24 | $6.21 |
| Revenue Next Year | $12.56 | $5.33 |
| P/E Ratio | ★ $27.27 | $29.19 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $47.50 | $89.41 |
| 52 Week High | $82.22 | $137.42 |
| Indicator | HALO | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 55.82 | 52.56 |
| Support Level | $67.94 | $89.41 |
| Resistance Level | $71.53 | $118.33 |
| Average True Range (ATR) | 1.83 | 3.89 |
| MACD | 0.66 | 1.67 |
| Stochastic Oscillator | 75.68 | 70.23 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.